Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

January 20, 2026

Kaneka Launches Enlight’s WaveSelect 1014 Neurovascular Guidewire in United States

January 20, 2026—Kaneka Medical America LLC, a subsidiary company of Kaneka Corporation, announced the United States launch of Enlight Medical Ltd.’s WaveSelect 1014 guidewire, through an exclusive distribution agreement. Kaneka is focused on embolization coil technology for neurovascular therapies.

The company stated that under the terms of the partnership, Kaneka will hold exclusive rights to distribute Enlight’s next-generation guidewire technology in the United States.

According to Kaneka, Enlight’s WaveSelect with polymer-metal matrix technology was originally designed and engineered in Japan with a focus on performance, microcatheter deliverability, and versatility across a wide range of neurovascular interventions.

Enlight Medical was founded in Boston, Massachusetts, and is currently located in China. It is focused on interventional medical devices for structural heart diseases and intravascular diseases, as well as neuromodulation products, noted Kaneka’s press release.

Advertisement

January 21, 2026

Cathpax Nova-X Radiation Protection System Studied for Interventional Neuroradiology Procedures

left-arrow Created with Sketch. Previous Article

January 16, 2026

C-GUARDIANS Data Published for InspireMD’s CGuard Prime Carotid Stent

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)